Episode 117: AML Series, Pt. 3 - AML Induction: Definitions and Overview
The Fellow on Call: The Heme/Onc Podcast
00:00
Importance of Molecular Testing and Risk Stratification in AML Treatment
This chapter highlights the critical role of molecular and cytogenetic testing in the management of acute myeloid leukemia (AML), focusing on genetic markers that shape treatment strategies. It also discusses how chromosomal abnormalities impact risk stratification and the phases of treatment for patients eligible for intensive chemotherapy.
Transcript
Play full episode
